Funder: NOVARTIS FARMACEUTICA, S.A.
date_range Duration: from 19 November 2024 to 18 March 2025 (4 months) Finished
euro 10,800.00 EUR

Of National scope. With a Private character.

Call: (NOVARTIS FARMACEUTICA, S.A.)

Researchers